Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy
To assess whether a therapeutic, subcutaneous injection of insulin exerts hemodynamic effects in subjects with IDDM, 0.2 U/kg regular insulin was injected subcutaneously in 17 IDDM subjects: 6 without autonomic neuropathy, 7 with autonomic neuropathy and othostatic hypotension, and 4 with autonomic...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 42; no. 7; pp. 1055 - 1064 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Diabetes Association
01.07.1993
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To assess whether a therapeutic, subcutaneous injection of insulin exerts hemodynamic effects in subjects with IDDM, 0.2 U/kg regular insulin was injected subcutaneously in 17 IDDM subjects: 6 without autonomic neuropathy, 7 with autonomic neuropathy and othostatic hypotension, and 4 with autonomic neuropathy but without orthostatic hypotension. Plasma glucose was maintained at approximately 8.5 mM throughout the studies. Mean blood pressure, plasma norepinephrine concentration, forearm vascular resistances, and calf venous volume were measured before and 120 min after subcutaneous insulin, in the supine position and 5 min after standing. Supine plasma volume ([125I]albumin and [131I]albumin) was measured before and after subcutaneous injection of insulin. In all three groups, subcutaneous insulin activated the sympathetic nervous system (approximately 30% increase in norepinephrine concentration). In subjects with IDDM but without autonomic neuropathy, standing forearm vascular resistance increased approximately 70% less after subcutaneous insulin, but supine or standing mean blood pressure did not decrease. In contrast, in subjects with IDDM with autonomic neuropathy and orthostatic hypotension, subcutaneous insulin decreased supine mean blood pressure (from 99 +/- 3 to 94 +/- 5 mmHg) and exaggerated the standing decrement in mean blood pressure (24 +/- 3 vs. 19 +/- 2 mmHg) (P < 0.05). This was associated with a decrease in forearm vascular resistance. Similarly, in subjects with IDDM with autonomic neuropathy without orthostatic hypotension, subcutaneously injected insulin decreased supine mean blood pressure (from 95 +/- 2 to 89 +/- 2 mmHg) and standing mean blood pressure by 8 +/- 1 mmHg (P < 0.05). Calf venous volume was not affected by subcutaneous insulin in any of the three groups. Plasma volume did not change after subcutaneous insulin in subjects with IDDM without autonomic neuropathy, whereas it decreased in those with autonomic neuropathy and orthostatic hypotension from 1.692 +/- 0.069 to 1.610 +/- 0.064 L/m2, without orthostatic hypotension from 1.631 +/- 0.027 to 1.593 +/- 0.024 L/m2, P < 0.05). No hemodynamic effects were observed when subjects with IDDM were restudied in a control experiment where placebo (distilled water), not insulin, was injected subcutaneously. In conclusion, therapeutic doses of subcutaneous insulin activate the sympathetic nervous system; decrease blood pressure in subjects with IDDM with autonomic neuropathy, but not in those without, primarily by decreasing arterial vascular resistances and plasma volume; and have no effects of capacitance vessels. Thus, in subjects with IDDM without autonomic neuropathy, greater activation of sympathetic nervous system after subcutaneous injection of insulin prevents orthostatic hypotension. |
---|---|
AbstractList | To assess whether a therapeutic, subcutaneous injection of insulin exerts hemodynamic effects in subjects with IDDM, 0.2 U/kg regular insulin was injected subcutaneously in 17 IDDM subjects: 6 without autonomic neuropathy, 7 with autonomic neuropathy and othostatic hypotension, and 4 with autonomic neuropathy but without orthostatic hypotension. Plasma glucose was maintained at ∼8.5 mM throughout the studies. Mean blood pressure, plasma norepinephrine concentration, forearm vascular resistances, and calf venous volume were measured before and 120 min after subcutaneous insulin, in the supine position and 5 min after standing. Supine plasma volume ([125I]albumin and [131I]albumin) was measured before and after subcutaneous injection of insulin. In all three groups, subcutaneous insulin activated the sympathetic nervous system (∼30% increase in norepinephrine concentration). In subjects with IDDM but without autonomic neuropathy, standing forearm vascular resistance increased ∼70% less after subcutaneous insulin, but supine or standing mean blood pressure did not decrease. In contrast, in subjects with IDDM with autonomic neuropathy and orthostatic hypotension, subcutaneous insulin decreased supine mean blood pressure (from 99 ± 3 to 94 ± 5 mmHg) and exaggerated the standing decrement in mean blood pressure (24 ± 3 vs. 19 ± 2 mmHg) (P < 0.05). This was associated with a decrease in forearm vascular resistance. Similarly, in subjects with IDDM with autonomic neuropathy without orthostatic hypotension, subcutaneously injected insulin decreased supine mean blood pressure (from 95 ± 2 to 89 ± 2 mmHg) and standing mean blood pressure by 8 ± 1 mmHg (P < 0.05). Calf venous volume was not affected by subcutaneous insulin in any of the three groups. Plasma volume did not change after subcutaneous insulin in subjects with IDDM without autonomic neuropathy, whereas it decreased in those with autonomic neuropathy and orthostatic hypotension from 1.692 ± 0.069 to 1.610 ± 0.064 L/m2, without orthostatic hypotension from 1.631 ± 0.027 to 1.593 ± 0.024 L/m2 P < 0.05). No hemodynamic effects were observed when subjects with IDDM were restudied in a control experiment where placebo (distilled water), not insulin, was injected subcutaneously. In conclusion, therapeutic doses of subcutaneous insulin activate the sympathetic nervous system; decrease blood pressure in subjects with IDDM with autonomic neuropathy, but not in those without, primarily by decreasing arterial vascular resistances and plasma volume; and have no effects of capacitance vessels. Thus, in subjects with IDDM without autonomic neuropathy, greater activation of sympathetic nervous system after subcutaneous injection of insulin prevents orthostatic hypotension. In contrast, in subjects with IDDM with autonomic neuropathy, the sympathetic nervous system failure unmasks the inhibition of sympathetic vasoconstriction by insulin, and blood pressure decreases, in part possibly because of insulin-induced decrease in plasma volume. To assess whether a therapeutic, subcutaneous injection of insulin exerts hemodynamic effects in subjects with IDDM, 0.2 U/kg regular insulin was injected subcutaneously in 17 IDDM subjects: 6 without autonomic neuropathy, 7 with autonomic neuropathy and othostatic hypotension, and 4 with autonomic neuropathy but without orthostatic hypotension. Plasma glucose was maintained at approximately 8.5 mM throughout the studies. Mean blood pressure, plasma norepinephrine concentration, forearm vascular resistances, and calf venous volume were measured before and 120 min after subcutaneous insulin, in the supine position and 5 min after standing. Supine plasma volume ([125I]albumin and [131I]albumin) was measured before and after subcutaneous injection of insulin. In all three groups, subcutaneous insulin activated the sympathetic nervous system (approximately 30% increase in norepinephrine concentration). In subjects with IDDM but without autonomic neuropathy, standing forearm vascular resistance increased approximately 70% less after subcutaneous insulin, but supine or standing mean blood pressure did not decrease. In contrast, in subjects with IDDM with autonomic neuropathy and orthostatic hypotension, subcutaneous insulin decreased supine mean blood pressure (from 99 +/- 3 to 94 +/- 5 mmHg) and exaggerated the standing decrement in mean blood pressure (24 +/- 3 vs. 19 +/- 2 mmHg) (P < 0.05). This was associated with a decrease in forearm vascular resistance. Similarly, in subjects with IDDM with autonomic neuropathy without orthostatic hypotension, subcutaneously injected insulin decreased supine mean blood pressure (from 95 +/- 2 to 89 +/- 2 mmHg) and standing mean blood pressure by 8 +/- 1 mmHg (P < 0.05). Calf venous volume was not affected by subcutaneous insulin in any of the three groups. Plasma volume did not change after subcutaneous insulin in subjects with IDDM without autonomic neuropathy, whereas it decreased in those with autonomic neuropathy and orthostatic hypotension from 1.692 +/- 0.069 to 1.610 +/- 0.064 L/m2, without orthostatic hypotension from 1.631 +/- 0.027 to 1.593 +/- 0.024 L/m2, P < 0.05). No hemodynamic effects were observed when subjects with IDDM were restudied in a control experiment where placebo (distilled water), not insulin, was injected subcutaneously. In conclusion, therapeutic doses of subcutaneous insulin activate the sympathetic nervous system; decrease blood pressure in subjects with IDDM with autonomic neuropathy, but not in those without, primarily by decreasing arterial vascular resistances and plasma volume; and have no effects of capacitance vessels. Thus, in subjects with IDDM without autonomic neuropathy, greater activation of sympathetic nervous system after subcutaneous injection of insulin prevents orthostatic hypotension. To assess whether a therapeutic, subcutaneous injection of insulin exerts hemodynamic effects in subjects with IDDM, 0.2 U/kg regular insulin was injected subcutaneously in 17 IDDM subjects: 6 without autonomic neuropathy, 7 with autonomic neuropathy and othostatic hypotension, and 4 with autonomic neuropathy but without orthostatic hypotension. Plasma glucose was maintained at 8.5 mM throughout the studies. Mean blood pressure, plasma norepinehprine concentration, forearm vascular resistances, and calf venous volume were measured before and 120 min after subcutaneous insulin, in the supine position and 5 min after standing. Supine plasma volume ([[sup.125 I]]albumin and [[sup.113I]]albumin) was measured before and after subcutaneous injection of insulin. In all three groups, subcutaneous insulin activated the sympathetic nervous system ( 30% increase in norepinephrine concentration). In subjects with IDDM but without autonomic neuropathy, standing forearm vascular resistance increased 70% less after subcutaneous insulin, but supine or standing mean blood pressure did not decrease. In contrast, in subjects with IDDM with autonomic neuropathy and orthostatic hypotension, subcutaneous insulin decreased supine mean blood pressure (from 99 [+ or -]3 to 94 [+ or -] 5 mmHg) and exaggerated the standing decrement in mean blood pressure (24 [+ or -] 3 vs. 19 [+ or -] 2 mmHg) (P < 0.05). This was associated with a decrease in forearm vascular resistance. Similarly, in subjects with IDDM with autonomic neuropathy without orthostatic hypotension, subcutaneously injected insulin decreased supine mean blood pressure (from 95 [+ or -] 2 to 89 [+ or -] 2 mmHg) and standing mean blood pressure by 8 [+ or -] 1 mmHg (P < 0.05). Calf venous volume was not affected by subcutaneous insulin in any of the three groups. Plasma volume did not change after subcutaneous insulin in subjects with IDDM without autonomic neuropathy, whereas it decreased in those with autonomic neuropathy and orthostatic hypotension from 1.692 [+ or -] 0.069 to 1.610 [plus or 0.064 L/M2, without orthostatic hypotension from 1.631 [+ or -] 0.027 to 1.593 [+ or -] 0.024 [L/M.sup.2], P < 0.05). No hemodynamic effects were observed when subjects with IDDM were restudied in a control experiment where placebo (distilled water), not insulin, was injected subcutaneously. In conclusion, therapeutic doses of subcutaneous insulin activate the sympathetic nervous system; decrease blood pressure in subjects with IDDM with autonomic neuropathy, but not in those without, primarily by decreasing arterial vascular resistances and plasma volume; and have no effects of capacitance vessels. Thus, in subjects with IDDM without autonomic neuropathy, greater activation of sympathetic nervous system after subcutaneous injection of insulin prevents orthostatic hypotension. In contrast, in subjects with IDDM with autonomic neuropathy, the sympathetic nervous system failure unmasks the inhibition of sympathetic vasoconstriction by insulin, and blood pressure decreases, in part possibly because of insulin-induced decrease in plasma volume. Diabetes 42:1055-64,1993 |
Audience | Professional |
Author | Brunetti, P Bottini, P Epifano, L Scionti, L Santeusanio, F Rambotti, A M Lalli, C Porcellati, F Fanelli, C Pampanelli, S |
Author_xml | – sequence: 1 givenname: F surname: Porcellati fullname: Porcellati, F organization: Institute of Internal Medicine, University of Perugia, Italy – sequence: 2 givenname: C surname: Fanelli fullname: Fanelli, C – sequence: 3 givenname: P surname: Bottini fullname: Bottini, P – sequence: 4 givenname: L surname: Epifano fullname: Epifano, L – sequence: 5 givenname: A M surname: Rambotti fullname: Rambotti, A M – sequence: 6 givenname: C surname: Lalli fullname: Lalli, C – sequence: 7 givenname: S surname: Pampanelli fullname: Pampanelli, S – sequence: 8 givenname: L surname: Scionti fullname: Scionti, L – sequence: 9 givenname: F surname: Santeusanio fullname: Santeusanio, F – sequence: 10 givenname: P surname: Brunetti fullname: Brunetti, P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8513972$$D View this record in MEDLINE/PubMed |
BookMark | eNptkU1r3DAQhkVJSTdJr70VfMyhdvVpWcewtGlhQy4J5CZkebyr4pWMPiD772OzoVAoAzPD8MzwMu8VuvDBA0JfCG4oY_L74EzfcNrIhmAhPqANUUzVjMqXC7TBmNCaSCU_oauU_mCM2yUu0WUnCFOSblB8AHsw3qVjqsJYmZghOjNVh9McMvjkgq_MuAyrfIBoZijZ2WoICVY8ld6WbDyEkirnU5mcX2q1ioIVNCUHH45L56HEMJt8ON2gj6OZEnx-r9fo-eePp-2vevd4_3t7t6stlSLXvIfWghmgY3Ice9IuyWDOR-iowGRgXBolFG4JEYMyynakk2rAHW-5IH3PrtHt-e7eTKCdt8FneM17U1LS3f1O3xGOJRGULOi3_6E2TBPsQS-yto__4M0ZtzGkFGHUc3RHE0-aYL26otcHaE611Ksry8LX88Jc-iMMf_F3G9gbYA-MEQ |
CitedBy_id | crossref_primary_10_4103_0019_5049_104564 crossref_primary_10_1016_j_dsx_2014_05_002 crossref_primary_10_1093_bja_85_1_80 crossref_primary_10_1136_pgmj_2007_062075 crossref_primary_10_1371_journal_pone_0084683 crossref_primary_10_1097_CRD_0b013e31815c8032 crossref_primary_10_1177_1474651412441223 crossref_primary_10_1139_h95_010 crossref_primary_10_1007_BF00571561 crossref_primary_10_1007_BF00400582 crossref_primary_10_1152_ajpendo_1994_267_2_E187 crossref_primary_10_1007_BF02658501 crossref_primary_10_1007_BF00400101 crossref_primary_10_1152_jappl_2001_90_3_889 crossref_primary_10_1007_BF00404337 |
ContentType | Journal Article |
Copyright | COPYRIGHT 1993 American Diabetes
Association COPYRIGHT 1993 American Diabetes Association |
Copyright_xml | – notice: COPYRIGHT 1993 American Diabetes Association – notice: COPYRIGHT 1993 American Diabetes Association |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 8GL |
DOI | 10.2337/diab.42.7.1055 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: High School |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
EndPage | 1064 |
ExternalDocumentID | A14071521 10_2337_diab_42_7_1055 8513972 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- .55 .GJ .XZ 08P 0R~ 18M 1CY 29F 2WC 354 3V. 4.4 53G 5GY 5RE 5RS 5VS 6PF 7RV 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8GL 8R4 8R5 AAKAS AAQQT AAWTL AAYEP AAYJJ AAYOK ABOCM ABUWG ACGFO ACGOD ACPRK ADBBV ADZCM AEGXH AENEX AERZD AFFNX AFHIN AFKRA AHMBA AI. AIAGR AIZAD ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBNVY BCR BCU BEC BENPR BES BHPHI BKEYQ BKNYI BLC BPHCQ BTFSW BVXVI C1A CCPQU CGR CS3 CUY CVF DIK DU5 DWQXO E3Z EBS ECM EDB EIF EJD EMOBN EX3 F5P FRP FYUFA GICCO GNUQQ GUQSH GX1 H13 HCIFZ HMCUK HZ~ H~9 IAG IAO IEA IHR INH INR IOF IPO ITC J5H K-O K2M K9- KQ8 L7B LK8 M0R M1P M2O M2P M2Q M5~ M7P MVM N4W NAPCQ NPM O5R O5S O9- OB3 OHH OK1 OVD P2P PCD PEA PQQKQ PROAC PSQYO Q2X RHF RHI RPM S0X SJFOW SJN SV3 TDI TEORI TR2 UKHRP VH1 VVN W8F WH7 WOQ WOW X7M XOL YFH YHG YOC YQJ ZGI ZXP ZY1 ~KM AAYXX CITATION |
ID | FETCH-LOGICAL-c275t-4be6ceade837ffb16ffba044fe82501d347a95906115d9a9c81879d0846451bb3 |
ISSN | 0012-1797 |
IngestDate | Thu Aug 01 20:27:55 EDT 2024 Fri Aug 23 07:50:52 EDT 2024 Fri Aug 23 03:32:42 EDT 2024 Sat Sep 28 08:33:00 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c275t-4be6ceade837ffb16ffba044fe82501d347a95906115d9a9c81879d0846451bb3 |
PMID | 8513972 |
PageCount | 10 |
ParticipantIDs | gale_incontextgauss_8GL_A14071521 gale_incontextcollege_GICCO_A14071521 crossref_primary_10_2337_diab_42_7_1055 pubmed_primary_8513972 |
PublicationCentury | 1900 |
PublicationDate | 1993-Jul |
PublicationDateYYYYMMDD | 1993-07-01 |
PublicationDate_xml | – month: 07 year: 1993 text: 1993-Jul |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationTitleAlternate | Diabetes |
PublicationYear | 1993 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
SSID | ssj0006060 |
Score | 1.6401597 |
Snippet | To assess whether a therapeutic, subcutaneous injection of insulin exerts hemodynamic effects in subjects with IDDM, 0.2 U/kg regular insulin was injected... |
SourceID | gale crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1055 |
SubjectTerms | Adult Analysis of Variance Blood Glucose - metabolism Blood Pressure - drug effects Development and progression Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 1 - drug therapy Diabetes Mellitus, Type 1 - physiopathology Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - physiopathology Diabetic neuropathies Diabetic Neuropathies - blood Diabetic Neuropathies - physiopathology Female Forearm - blood supply Health aspects Heart Rate - drug effects Humans Hypotension Hypotension - chemically induced Injections, Subcutaneous Insulin Insulin - administration & dosage Insulin - blood Insulin - therapeutic use Male Middle Aged Norepinephrine - blood Plasma Volume - drug effects Posture Regional Blood Flow - drug effects Supine Position Vascular Resistance - drug effects |
Title | Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8513972 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZWRUJcEK-K5SUjgTisdomdZJMcq5ZSoAscWqk3y_HasIduVk1yaH8Gv5gZ28k6qx4KF2cVWY7l-daeGX8zQ8g70KglaEPF1MxBfUtKw6dyqRhshoZHRsZwhmDs8OL7_OQ8-XqRXoxGfwLWUtuUM3Vza1zJ_0gV3oFcMUr2HyTbDwov4DfIF1qQMLR3kvFCY9zuqr60fAzLzkQH-O_rTWWJ6X0N8CDKarKsnPu-bkvVgmqokQTbUdKRG2u9sZjGtW1c0PLEJr3E2sWDO-CjwG27W9AncDD8rOztgHS8AVvIQ9dbgtCxRKLNypNPLsNr_go52Sun58Ie3Sv_m5WRtmL45LRVvmqSd104omA2oIF0d1L9fHch6TdtxjGLahZu2gkPwJkFOzAW_LztaOCxTS6AazhL-CybdR130m0fMDRxU8xNcI9nRYoG_dGXb_3pDgafC2vyk3KJQHH0j8OxB4qOP-4HlovVYM4ekYfe9KAHDkePyUivn5D7C0-ueEqutnCilaEdnGgAJ2rhRAM4UYQTdg_hRD2c4Ek7ONEeTnQLp2fk_PjT2eHJ1JfkmCqepQ38mfVcIcc-jzNjSjaHRkZJYnQOujRbxkkmi7QAJZGly0IWKsdq9ssoxwt0VpbxPtlbV2v9nFDYJXTOZK6hUxKpWKZlpLRJNcOasQUbkw_d-omNy7wiwGLFlRY4dZFwkQlc6TF5j8srMJ3JGvlSyvncBMz88IfoJTomb4f9fsm2rkX--TTss-9k1H8TTBLQ2fmLO37kJXmwhforstdctfo16K1N-cYC6S-BI55i |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanisms+of+arterial+hypotension+after+therapeutic+dose+of+subcutaneous+insulin+in+diabetic+autonomic+neuropathy&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Porcellati%2C+Francesca&rft.au=Fanelli%2C+Carmine&rft.au=Bottini%2C+Paolo&rft.au=Epifano%2C+Lucilla&rft.date=1993-07-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.volume=42&rft.issue=7&rft.spage=1055&rft_id=info:doi/10.2337%2Fdiab.42.7.1055&rft.externalDocID=A14071521 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |